Literature DB >> 33500852

Current Knowledge of Hypertrophic Cardiomyopathy Among Health Care Providers in Sweden.

Peter Magnusson1,2, Stellan Mörner3.   

Abstract

Introduction Hypertrophic cardiomyopathy (HCM) is a common disorder with various manifestations, including sudden cardiac death. Patients with suspected or confirmed HCM may be encountered throughout the healthcare system, especially in internal medicine and cardiology. Thus, thorough knowledge of HCM is essential among healthcare providers. Methods A web-based questionnaire was developed to assess the cross-sectional evaluation of HCM knowledge. It covered aspects such as epidemiology and diagnosis, treatment, lifestyle, risk stratification of sudden cardiac death, and implantable cardioverter-defibrillator knowledge. Results In total, 123 subjects completed the survey. The mean age was 38.5 ±10.7 years and two-thirds (n=82) were females; 43.1% were physicians (non-specialist 24.4%, cardiologists 8.9%, specialist, other than cardiology 9.8%); and the remaining were nurses (nurses within cardiology 37.4%, nurses outside cardiology 19.5%). Almost all subjects had heard about the disease (95.9%) and the vast majority (77.2%) had taken part in the management of a patient with HCM. The total mean score was 15.9 ±3.9 credits and the 25th, 50th, and 75th percentiles were 14, 15, and 18 credits, respectively. The predefined arbitrary pass score of ≥60% was reached by 61.8%, and 20.3% were considered to pass with distinction. Physicians scored higher than nurses (70.7 ±17.0% vs 58.1 ±11.8; p<0.001). Within each professional category, there was a similar score with regard to gender. Conclusions There is a considerable lack of knowledge of HCM among healthcare professionals working within the field of internal medicine/cardiology. This insufficient knowledge may contribute to less implementation of evidence-based medicine and current guidelines, although further studies are needed to confirm this.
Copyright © 2020, Magnusson et al.

Entities:  

Keywords:  arrhythmia; hypertrophic cardiomyopathy; sudden cardiac death

Year:  2020        PMID: 33500852      PMCID: PMC7819499          DOI: 10.7759/cureus.12220

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  21 in total

Review 1.  Integrated regional genetic services: current and future provision.

Authors:  D Donnai; R Elles
Journal:  BMJ       Date:  2001-04-28

2.  2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Authors:  Bernard J Gersh; Barry J Maron; Robert O Bonow; Joseph A Dearani; Michael A Fifer; Mark S Link; Srihari S Naidu; Rick A Nishimura; Steve R Ommen; Harry Rakowski; Christine E Seidman; Jeffrey A Towbin; James E Udelson; Clyde W Yancy
Journal:  Circulation       Date:  2011-11-08       Impact factor: 29.690

Review 3.  Application of Genetic Testing in Hypertrophic Cardiomyopathy for Preclinical Disease Detection.

Authors:  Jodie Ingles; Charlotte Burns; Alexandra Barratt; Christopher Semsarian
Journal:  Circ Cardiovasc Genet       Date:  2015-12

Review 4.  Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.

Authors:  Roberto M Lang; Luigi P Badano; Victor Mor-Avi; Jonathan Afilalo; Anderson Armstrong; Laura Ernande; Frank A Flachskampf; Elyse Foster; Steven A Goldstein; Tatiana Kuznetsova; Patrizio Lancellotti; Denisa Muraru; Michael H Picard; Ernst R Rietzschel; Lawrence Rudski; Kirk T Spencer; Wendy Tsang; Jens-Uwe Voigt
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2015-03       Impact factor: 6.875

5.  Long-term outcomes for different surgical strategies to treat left ventricular outflow tract obstruction in hypertrophic cardiomyopathy.

Authors:  Richard Collis; Oliver Watkinson; Constantinos O'Mahony; Oliver P Guttmann; Antonis Pantazis; Maria Tome-Esteban; Victor Tsang; Venkatachalam Chandrasekaran; Christopher G A McGregor; Perry M Elliott
Journal:  Eur J Heart Fail       Date:  2017-11-16       Impact factor: 15.534

6.  Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy.

Authors:  Pascale Richard; Philippe Charron; Lucie Carrier; Céline Ledeuil; Theary Cheav; Claire Pichereau; Abdelaziz Benaiche; Richard Isnard; Olivier Dubourg; Marc Burban; Jean-Pierre Gueffet; Alain Millaire; Michel Desnos; Ketty Schwartz; Bernard Hainque; Michel Komajda
Journal:  Circulation       Date:  2003-04-21       Impact factor: 29.690

7.  Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer.

Authors:  Gilbert Habib; Bruno Hoen; Pilar Tornos; Franck Thuny; Bernard Prendergast; Isidre Vilacosta; Philippe Moreillon; Manuel de Jesus Antunes; Ulf Thilen; John Lekakis; Maria Lengyel; Ludwig Müller; Christoph K Naber; Petros Nihoyannopoulos; Anton Moritz; Jose Luis Zamorano
Journal:  Eur Heart J       Date:  2009-08-27       Impact factor: 29.983

8.  Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases.

Authors:  Perry Elliott; Bert Andersson; Eloisa Arbustini; Zofia Bilinska; Franco Cecchi; Philippe Charron; Olivier Dubourg; Uwe Kühl; Bernhard Maisch; William J McKenna; Lorenzo Monserrat; Sabine Pankuweit; Claudio Rapezzi; Petar Seferovic; Luigi Tavazzi; Andre Keren
Journal:  Eur Heart J       Date:  2007-10-04       Impact factor: 29.983

9.  Prevalence of idiopathic hypertrophic cardiomyopathy in China: a population-based echocardiographic analysis of 8080 adults.

Authors:  Yubao Zou; Lei Song; Zhimin Wang; Aiqun Ma; Tangwei Liu; Huimin Gu; Sailan Lu; Pengzhu Wu; Ying Zhang dagger; Li Shen dagger; Yuling Cai; Yisong Zhen double dagger; Yanling Liu; Rutai Hui
Journal:  Am J Med       Date:  2004-01-01       Impact factor: 4.965

10.  Physicians' knowledge of implantable defibrillator treatment: are we good enough?

Authors:  Annika Kinch Westerdahl; Viveka Frykman
Journal:  Europace       Date:  2017-07-01       Impact factor: 5.214

View more
  1 in total

1.  Practitioners' Confidence and Desires for Education in Cardiovascular and Sudden Cardiac Death Genetics.

Authors:  Laura Lopez Santibanez Jacome; Lisa M Dellefave-Castillo; Catherine A Wicklund; Courtney L Scherr; Debra Duquette; Gregory Webster; Maureen E Smith; Kerstin Kalke; Adam S Gordon; Kristen De Berg; Elizabeth M McNally; Laura J Rasmussen-Torvik
Journal:  J Am Heart Assoc       Date:  2022-03-24       Impact factor: 6.106

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.